Mark Jacobs
- Hematology top 5%
- Acute Myeloid Leukemia Research 2
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Internal Medicine top 10%
-
- Atrial Fibrillation Management and Outcomes 4
- Cardiac pacing and defibrillation studies 2
- Cardiac Arrhythmias and Treatments 2
-
- Colorectal Cancer Treatments and Studies 2
-
- Infective Endocarditis Diagnosis and Management 2
-
- Mechanical Circulatory Support Devices 2
- Co-authors
- P. ScigallaWalter FiedlerHubert ServeA O’FarrellWolfgang E. BerdelSharianne G. LouieCarlo L. BelloWilliam C. Manning
- Cited by
- HematologyGeneticsInternal Medicine
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mark Jacobs
11 papers receiving 632 citations
Peers
Comparison fields: 5 of 69
- Hematology 313
- Genetics 138
- Internal Medicine 46
- Cardiology and Cardiovascular Medicine 116
- Cancer Research 72
Countries citing papers authored by Mark Jacobs
This map shows the geographic impact of Mark Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jacobs more than expected).
Fields of papers citing papers by Mark Jacobs
This network shows the impact of papers produced by Mark Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jacobs. The network helps show where Mark Jacobs may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Jacobs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 1 | |
| 8 | 2020 | 1 | |
| 9 | 2016 | 112 | |
| 10 | 2007 | 1 | |
| 11 | 2007 | 7 | |
| 12 | 2006 | 55 | |
| 13 | 2005 | 1 | |
| 14 | 2003 | 214 | |
| 15 | An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients. | 2003 | 261 |
| 16 | Speakeasy Studio and Cafe: Information Literacy, Web-based Library Instruction, and Technology. | 2001 | 6 |
| 17 | Introducing a Directory Service | 1995 | 0 |
About Mark Jacobs
Mark Jacobs is a scholar working on Library and Information Sciences, Internal Medicine and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 660 indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (4 papers), Acute Myeloid Leukemia Research (2 papers), Cardiac pacing and defibrillation studies (2 papers), Cardiac Arrhythmias and Treatments (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Infective Endocarditis Diagnosis and Management (2 papers) and Mechanical Circulatory Support Devices (2 papers). The work is most often cited by research in Hematology (313 citations), Genetics (138 citations) and Internal Medicine (46 citations). Mark Jacobs has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include P. Scigalla, Walter Fiedler, Hubert Serve, A O’Farrell, Wolfgang E. Berdel, Sharianne G. Louie, Carlo L. Bello, William C. Manning, Julie M. Cherrington and Stephen M. Kelsey. Their work appears in journals such as Journal of Clinical Oncology, Circulation, JACC Heart Failure, Journal of Personalized Medicine and EP Europace.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.